Silica Nanoparticle-Cell Construct for Targeted Platinum Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems, such as liposomes and nanoparticles, face challenges in maintaining structural stability under fluid shear stress and effectively targeting tumors, while Neural Stem Cells (NSCs) lack intrinsic anti-tumor efficacy and require enhanced methods for targeted chemotherapeutic delivery.

Innovation Solution

Development of silica nanoparticles conjugated with platinum anti-cancer agents through oxygen or nitrogen linkers, combined with NSCs, to create a nanoparticle-cell construct for targeted and selective tumor killing, utilizing delayed drug release mechanisms for enhanced therapeutic efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If liposomes are used for drug delivery, then high drug loadings are achieved, but structural stability under fluid shear stress is undesirably low

Engineering Contradiction:
Improvedrug loadingVSAvoidstructural stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The invention uses composite silica nanoparticles that combine the high drug loading capacity of porous materials with the structural stability of inorganic silica framework, resolving the contradiction between soft liposome flexibility and structural integrity under shear stress

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If Neural Stem Cells are used for targeted delivery, then tumor tropic properties are achieved, but intrinsic anti-tumor efficacy is absent

Engineering Contradiction:
Improvetargeting capabilityVSAvoidanti-tumor efficacy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The invention merges the targeting capability of Neural Stem Cells with the anti-tumor efficacy of platinum drugs by covalently conjugating the drug to the cell surface, creating a hybrid system that combines both functions in a single delivery vehicle

Inventive Principle:
Principle #5Merging (Combining)

3Object-affected harmful factors

If NSAIDs are used to reduce inflammation, then inflammatory response is reduced, but tumor growth may be promoted

Engineering Contradiction:
Improveinflammatory responseVSAvoidtumor growth promotion
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The invention uses silica nanoparticles as an intermediary carrier that delivers platinum drugs directly to tumor sites, bypassing the systemic anti-inflammatory effects of NSAIDs that promote tumor growth, while still allowing localized control of inflammation at the tumor microenvironment

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The silica nanoparticle-cell constructs demonstrate superior accumulation and retention of platinum agents at tumor sites, achieving effective tumor killing and overcoming stability and targeting limitations of existing systems.

Implementation Method 1

the platinum anti-cancer agent is conjugated to silica directly, though an oxygen linker, or through a nitrogen linker

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

The silica nanoparticle-cell constructs demonstrate superior accumulation and retention of platinum agents at tumor sites

Methodology Applied
Scientific EffectTargeted delivery:

Implementation Method 3

achieving effective tumor killing

Methodology Applied
Scientific EffectAnti-cancer agent activity:

Data Source

PatentUS11696959B2Nanoparticle-cell construct with platinum anti-cancer agent
Publication Date: 2023.07.11 CITY OF HOPE
  • US11696959B2 patent drawing
  • US11696959B2 patent drawing
  • US11696959B2 patent drawing

AI summary

The disclosure provides, inter alia, compositions including cell-nanoparticle constructs and drug loaded nanoparticles, and methods for their use in the treatment of cancer. Also provided are unmodified cisplatin molecules encapsulated by silica nanoparticles, and their use in the treatment of cancer.